Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Use of Zolpidem in Parkinson's Disease
A Randomized, Controlled, Double-Blind, Cross-over Study of Zolpidem for Patients With Parkinson's Disease
Status: Enrolling
Updated:  5/9/2011
Rush University Medical Center
mi
from
Chicago, IL
Use of Zolpidem in Parkinson's Disease
A Randomized, Controlled, Double-Blind, Cross-over Study of Zolpidem for Patients With Parkinson's Disease
Status: Enrolling
Updated: 5/9/2011
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
PRISM Registry: Pseudobulbar Affect Registry Series
PRISM Registry: Pseudobulbar Affect Registry Series
Status: Enrolling
Updated:  6/2/2011
Avanir Pharmaceuticals
mi
from
Aliso Viejo, CA
PRISM Registry: Pseudobulbar Affect Registry Series
PRISM Registry: Pseudobulbar Affect Registry Series
Status: Enrolling
Updated: 6/2/2011
Avanir Pharmaceuticals
mi
from
Aliso Viejo, CA
Click here to add this to my saved trials
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Status: Enrolling
Updated:  6/24/2011
Oregon Clinical Translational Research Institute
mi
from
Portland, OR
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Status: Enrolling
Updated: 6/24/2011
Oregon Clinical Translational Research Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
University of Southern California
mi
from
Los Angeles, CA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Eastern Connecticut Neurology Specialists, LLC
mi
from
Manchester, CT
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Eastern Connecticut Neurology Specialists, LLC
mi
from
Manchester, CT
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Parkinson's Disease and Movement Disorders Center of Boca Raton
mi
from
Boca Raton, FL
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Parkinson's Disease and Movement Disorders Center of Boca Raton
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Rush University Medical Center
mi
from
Chicago, IL
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Ochsner Medical Center
mi
from
New Orleans, LA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Massachusetts General Hospital
mi
from
Boston, MA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Boston University Medical Center
mi
from
Boston, MA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Michigan State University
mi
from
East Lansing, MI
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Struthers Parkinson's Center
mi
from
Golden Valley, MN
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Struthers Parkinson's Center
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Mt. Sinai Medical Center
mi
from
New York, NY
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Duke University School of Medicine
mi
from
Durham, NC
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Duke University School of Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
University of Cincinnati
mi
from
Cincinnati, OH
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Cleveland Clinic
mi
from
Cleveland, OH
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Oregon Health and Science University
mi
from
Portland, OR
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Butler Hospital Movement Disorder Program
mi
from
Providence, RI
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Butler Hospital Movement Disorder Program
mi
from
Providence, RI
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Scott & White Hospital
mi
from
Temple, TX
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Scott & White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
University of Alabama-Birmingham (UAB)
mi
from
Birmingham, AL
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
University of Alabama-Birmingham (UAB)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
University of South Florida
mi
from
Tampa, FL
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
Rush University Medical Center
mi
from
Chicago, IL
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
Duke University
mi
from
Durham, NC
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
The Effect of Exercise on Individuals With Parkinson's Disease
The Effect of Exercise on Individuals With Parkinson's Disease
Status: Enrolling
Updated:  8/9/2011
Clinical Motor Control Laboratory at the University of Illinois at Chicago
mi
from
Chicago, IL
The Effect of Exercise on Individuals With Parkinson's Disease
The Effect of Exercise on Individuals With Parkinson's Disease
Status: Enrolling
Updated: 8/9/2011
Clinical Motor Control Laboratory at the University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
The Effect of Donepezil on Gait and Balance in Parkinson's Disease
A Randomized, Double-blind, Placebo Controlled, Crossover Study to Evaluate the Effect of Donepezil on Gait and Balance in Parkinson's Disease
Status: Enrolling
Updated:  1/25/2012
Parkinson's Center of Oregon - Oregon Health and Science University
mi
from
Portland, OR
The Effect of Donepezil on Gait and Balance in Parkinson's Disease
A Randomized, Double-blind, Placebo Controlled, Crossover Study to Evaluate the Effect of Donepezil on Gait and Balance in Parkinson's Disease
Status: Enrolling
Updated: 1/25/2012
Parkinson's Center of Oregon - Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease
Effect of a Structured Physical Activity Program on Sleep Quality and Sleepiness in Parkinson's Disease
Status: Enrolling
Updated:  2/28/2012
Northwestern University
mi
from
Chicago, IL
Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease
Effect of a Structured Physical Activity Program on Sleep Quality and Sleepiness in Parkinson's Disease
Status: Enrolling
Updated: 2/28/2012
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease
A Phase II, Double-Blind, Placebo-Controlled Randomized Crossover Study to Assess the Clinical Benefit and Safety of Droxidopa in the Treatment of Freezing of Gait Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  3/6/2012
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease
A Phase II, Double-Blind, Placebo-Controlled Randomized Crossover Study to Assess the Clinical Benefit and Safety of Droxidopa in the Treatment of Freezing of Gait Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 3/6/2012
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
The ParkCycle Study
The ParkCycle Study: Effects of Aerobic Exercise on Cognitive and Adaptive Plasticity in Parkinson's Disease
Status: Enrolling
Updated:  3/22/2012
Cleveland Clinic
mi
from
Cleveland, OH
The ParkCycle Study
The ParkCycle Study: Effects of Aerobic Exercise on Cognitive and Adaptive Plasticity in Parkinson's Disease
Status: Enrolling
Updated: 3/22/2012
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Birmingham, AL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Birmingham, AL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Cleveland, OH
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Cleveland, OH
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
mi
from
Dallas, TX
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
mi
from
Dallas, TX
Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease
Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease
Status: Enrolling
Updated:  4/20/2012
Michael E. DeBakey Veteran Affairs Medical Center
mi
from
Houston, TX
Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease
Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease
Status: Enrolling
Updated: 4/20/2012
Michael E. DeBakey Veteran Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated:  5/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated: 5/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
mi
from
Washington,
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
mi
from
Park Ridge, IL
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
mi
from
Chattanooga, TN
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
mi
from
Dallas, TX
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease
Status: Enrolling
Updated:  6/21/2012
Department of Neurosurgery, University of Minnesota
mi
from
Minneapolis, MN
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease
Status: Enrolling
Updated: 6/21/2012
Department of Neurosurgery, University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Neurology Neurodiagnostic Lab
mi
from
Alabaster, AL
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Neurology Neurodiagnostic Lab
mi
from
Alabaster, AL
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Neurological Physicians of Arizona
mi
from
Gilbert, AZ
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Neurological Physicians of Arizona
mi
from
Gilbert, AZ
Click here to add this to my saved trials